Literature DB >> 18941718

Alzheimer's disease and other dementing conditions.

Gioacchino Tedeschi1, Mario Cirillo, Alessandro Tessitore, Sossio Cirillo.   

Abstract

Dementia is a common and growing problem, with 20% of those over 80 years of age suffering from this disorder. The prospect of more effective treatments has caused an increasing demand for a more accurate and earlier diagnosis of different dementia syndromes. Neuroimaging techniques may have an important role in the clinical evaluation of dementia for early diagnosis, differential diagnosis and may help in the prediction of conversion to dementia in individuals at a higher risk of developing the disorder. Moreover, new MRI techniques might not only further broaden our understanding of the pathophysiology but also accelerate treatment discovery. This review will focus on the use of conventional and non-conventional MRI techniques to investigate dementias.

Entities:  

Mesh:

Year:  2008        PMID: 18941718     DOI: 10.1007/s10072-008-1003-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  47 in total

1.  Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD.

Authors:  D J Callen; S E Black; F Gao; C B Caldwell; J P Szalai
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

2.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water.

Authors:  K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

3.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia.

Authors:  H J Rosen; M L Gorno-Tempini; W P Goldman; R J Perry; N Schuff; M Weiner; R Feiwell; J H Kramer; B L Miller
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

4.  Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study.

Authors:  M Bozzali; A Falini; M Cercignani; F Baglio; E Farina; M Alberoni; P Vezzulli; F Olivotto; F Mantovani; T Shallice; G Scotti; N Canal; R Nemni
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

5.  Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI.

Authors:  D K Jones; D Lythgoe; M A Horsfield; A Simmons; S C Williams; H S Markus
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

6.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

7.  Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  G D Rabinovici; W W Seeley; E J Kim; M L Gorno-Tempini; K Rascovsky; T A Pagliaro; S C Allison; C Halabi; J H Kramer; J K Johnson; M W Weiner; M S Forman; J Q Trojanowski; S J Dearmond; B L Miller; H J Rosen
Journal:  Am J Alzheimers Dis Other Demen       Date:  2007 Dec-2008 Jan       Impact factor: 2.035

8.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Authors:  Mona K Beyer; Jan P Larsen; Dag Aarsland
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

9.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

10.  Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD.

Authors:  Josephine Barnes; Alison K Godbolt; Chris Frost; Richard G Boyes; Bethany F Jones; Rachael I Scahill; Martin N Rossor; Nick C Fox
Journal:  Neurobiol Aging       Date:  2006-01-06       Impact factor: 4.673

View more
  5 in total

1.  Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer's disease.

Authors:  Rui Yang; Qingjun Wang; Lianqiu Min; Rubo Sui; Jian Li; Xuewen Liu
Journal:  Neurol Sci       Date:  2012-12-11       Impact factor: 3.307

Review 2.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

3.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh Togha; Hamed Cheraghmakani; Soodeh Razeghi; Seyyed Shamssedin Hejazi; Mohammad Hossein Yousefi; Roozbeh Alimardani; Amirhossein Jamshidi; Shams-Ali Rezazadeh; Aboulghasem Yousefi; Farhad Zare; Atbin Moradi; Ardalan Vossoughi
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

Review 4.  Perception of Alzheimer Disease in Iranian Traditional Medicine.

Authors:  Rostam Saifadini; Haleh Tajadini; Rasool Choopani; Mitra Mehrabani; Mohamad Kamalinegad; Aliakbar Haghdoost
Journal:  Iran Red Crescent Med J       Date:  2016-03-01       Impact factor: 0.611

Review 5.  Epidemiology and Risk Factors of Alzheimer's Disease in Iran: A Systematic Review.

Authors:  Elham Navipour; Mahbobeh Neamatshahi; Zahra Barabadi; Mohammad Neamatshahi; Aghilallah Keykhosravi
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.